Fig. 5. mRNA levels in the border zone 14 days after infarction (7 days after starting therapy). a. c-KIT; b. Sca-1; c. Ki-67; d. CD31; e. CD34; f. CD133; g. CD44; h. CD105; i. CD146. There were 4 samples in each group. * p<0.008 vs. Cont. † p<0.03 vs. TIC. ASA- aspirin; Cont- control; PRAS- prasugrel; TIC- ticagrelor.